RKDA Earnings Arcadia Biosciences, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–33 of 33
| Q2 2026 | 2026-06-30 | -2.09 | 2026-08-13 | 10-Q |
| Q1 2026 | 2026-03-31 | -2.11 | 2026-05-14 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -0.97 | 2026-03-26 | 10-K |
| FY 2025 | 2025-12-31 | -1.71 | 2026-03-26 | 10-K |
| Q3 2025 | 2025-09-30 | 0.62 | 2025-11-07 | 10-Q |
| Q2 2025 | 2025-06-30 | -3.26 | 2025-08-14 | 10-Q |
| Q1 2025 | 2025-03-31 | 1.90 | 2025-05-08 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | -2.99 | 2025-03-25 | 10-K |
| FY 2024 | 2024-12-31 | -5.17 | 2025-03-25 | 10-K |
| Q3 2024 | 2024-09-30 | -1.18 | 2024-11-12 | 10-Q |
| Q2 2024 | 2024-06-30 | 0.78 | 2024-08-13 | 10-Q |
| Q1 2024 | 2024-03-31 | -1.78 | 2024-05-13 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | 0.85 | — | — |
| FY 2023 | 2023-12-31 | -11.29 | — | — |
| Q3 2023 | 2023-09-30 | -1.89 | 2023-11-09 | 10-Q |
| Q2 2023 | 2023-06-30 | 0.61 | 2023-08-10 | 10-Q |
| Q1 2023 | 2023-03-31 | -10.86 | 2023-05-15 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -6.08 | 2023-03-30 | 10-K |
| FY 2022 | 2022-12-31 | -25.65 | 2023-03-30 | 10-K |
| Q3 2022 | 2022-09-30 | -4.67 | 2022-11-10 | 10-Q |
| Q2 2022 | 2022-06-30 | -6.81 | 2022-08-11 | 10-Q |
| Q1 2022 | 2022-03-31 | -8.09 | 2022-05-12 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | -31.62 | — | — |
| FY 2021 | 2021-12-31 | -27.56 | — | — |
| Q3 2021 | 2021-09-30 | -0.10 | — | — |
| Q2 2021 | 2021-06-30 | -0.24 | — | — |
| Q1 2021 | 2021-03-31 | 4.40 | 2021-05-17 | 10-Q |
| Q3 2020 | 2020-09-30 | -24.00 | 2020-11-13 | 10-Q |
| Q2 2020 | 2020-06-30 | -41.60 | 2020-08-13 | 10-Q |
| Q1 2020 | 2020-03-31 | 11.60 | 2020-05-13 | 10-Q |
| Q3 2019 | 2019-09-30 | -81.60 | — | — |
| Q2 2019 | 2019-06-30 | 33.60 | — | — |
| Q1 2019 | 2019-03-31 | -105.60 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.